» Articles » PMID: 33127316

Increase in Number of Depression Symptoms Over Time is Related to Worse Cognitive Outcomes in Older Adults With Type 2 Diabetes

Overview
Publisher Elsevier
Specialty Geriatrics
Date 2020 Oct 31
PMID 33127316
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Older adults with type 2 diabetes (T2D) are at increased risk for depression, cognitive decline, and dementia compared to those without T2D. Little is known about the association of simultaneous changes in depression symptoms and cognitive decline over time.

Methods: Subjects (n=1021; mean age 71.6 [SD=4.6]; 41.2% female) were initially cognitively normal participants of the Israel Diabetes and Cognitive Decline study who underwent evaluations of depression and cognition approximately every 18 months. Cognitive tests were summarized into four cognitive domains: episodic memory, attention/working memory, executive functions, and semantic categorization. The average of the z-scores of the four domains defined global cognition. Depression symptoms were assessed using the Geriatric Depression Scale, 15-item version. We fit a random coefficients model of changes in depression and in cognitive functions, adjusting for baseline sociodemographic and cardiovascular variables.

Results: Higher number of depression symptoms at baseline was significantly associated with lower baseline cognitive scores in global cognition (estimate = -0.1175, SE = 0.021, DF = 1,014, t = -5.59; p < 0.001), executive functions (estimate = -0.186, SE = 0.036, DF = 1,013, t = -5.15; p = <0.001), semantic categorization (estimate = -0.155, SE = 0.029, DF = 1,008, t = -5.3; p < 0.001), and episodic memory (estimate = -0.08165, SE = 0.027, DF = 1,035, t = -2.92; p = 0.0036), but not with rate of decline in any cognitive domain. During follow-up, a larger increase in number of depression symptoms, was associated with worse cognitive outcomes in global cognition (estimate = -0.1053, SE = 0.027, DF = 1,612, t = -3.77; p = 0.0002), semantic categorization (estimate = -0.123, SE = 0.036, DF = 1,583, t = -3.36; p = 0.0008), and in episodic memory (estimate = -0.165, SE = 0.055, DF = 1,622, t = -3.02; p = 0.003), but the size of this effect was constant over time.

Conclusion: In elderly with T2D, increase in depression symptoms over time is associated with parallel cognitive decline, indicating that the natural course of the two conditions progresses concurrently and suggesting common underlying mechanisms".

Citing Articles

Association Between Depressive Symptoms and Comorbidities Among Elderly Diabetic Individuals in China.

Qiao L, Pan X, Li T, Yi S, Tang Z Brain Behav. 2024; 15(1):e70232.

PMID: 39740788 PMC: 11688112. DOI: 10.1002/brb3.70232.


Neurological and metabolic related pathophysiologies and treatment of comorbid diabetes with depression.

Li S, Yang D, Zhou X, Chen L, Liu L, Lin R CNS Neurosci Ther. 2023; 30(4):e14497.

PMID: 37927197 PMC: 11017426. DOI: 10.1111/cns.14497.


Correlation analysis of monocyte chemoattractant protein-1 and clinical characteristics and cognitive impairment in type 2 diabetes mellitus comorbid major depressive disorder.

Cao F, Yang M, Cheng Y, Zhang X, Shi L, Li N Front Aging Neurosci. 2023; 15:1081393.

PMID: 37213540 PMC: 10192629. DOI: 10.3389/fnagi.2023.1081393.


The role of medication adherence in the association between depressive symptoms and quality of life in older adults with type 2 diabetes mellitus.

Yang H, Wu F, Gui M, Cheng Y, Zhang L BMC Geriatr. 2023; 23(1):196.

PMID: 36997851 PMC: 10064516. DOI: 10.1186/s12877-023-03929-8.


Decrease in Gait Speed Over Time Is Associated With Increase in Number of Depression Symptoms in Older Adults With Type 2 Diabetes.

Lavie I, Beeri M, Schwartz Y, Soleimani L, Heymann A, Azuri J J Gerontol A Biol Sci Med Sci. 2023; 78(8):1504-1512.

PMID: 36626301 PMC: 10395563. DOI: 10.1093/gerona/glad008.


References
1.
LaMonica H, Hickie I, Ip J, Ireland C, Mowszowski L, English A . Disability in older adults across the continuum of cognitive decline: unique contributions of depression, sleep disturbance, cognitive deficits and medical burden. Int Psychogeriatr. 2019; 31(11):1611-1625. DOI: 10.1017/S1041610218002144. View

2.
Jorm A, Anstey K, Christensen H, de Plater G, Kumar R, Wen W . MRI hyperintensities and depressive symptoms in a community sample of individuals 60-64 years old. Am J Psychiatry. 2005; 162(4):699-705. DOI: 10.1176/appi.ajp.162.4.699. View

3.
Norton S, Matthews F, Barnes D, Yaffe K, Brayne C . Potential for primary prevention of Alzheimer's disease: an analysis of population-based data. Lancet Neurol. 2014; 13(8):788-94. DOI: 10.1016/S1474-4422(14)70136-X. View

4.
Deschenes S, Burns R, Pouwer F, Schmitz N . Diabetes Complications and Depressive Symptoms: Prospective Results From the Montreal Diabetes Health and Well-Being Study. Psychosom Med. 2017; 79(5):603-612. DOI: 10.1097/PSY.0000000000000447. View

5.
Wilson R, Capuano A, Boyle P, Hoganson G, Hizel L, Shah R . Clinical-pathologic study of depressive symptoms and cognitive decline in old age. Neurology. 2014; 83(8):702-9. PMC: 4150132. DOI: 10.1212/WNL.0000000000000715. View